James Lordan
- Static lung volumes in lung transplant recipients with bronchiolitis obliterans syndromeBy Therese Small, Christopher Ward, James Lordan, Andrew Fisher, Paul Corris and John GibsonTherese Small1Sir William Leech Centre for Lung Research, Freeman Hospital, Newcastle upon Tyne, United KingdomChristopher Ward2Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United KingdomJames Lordan1Sir William Leech Centre for Lung Research, Freeman Hospital, Newcastle upon Tyne, United KingdomAndrew Fisher2Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United KingdomPaul Corris2Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United KingdomJohn Gibson2Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
- BAL neutrophil levels in a randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome post lung transplantationBy Chris Ward, Gail Johnson, Victoria Ryan, Therese Small, James Lordan, Andrew Fisher, Gerard Meachery and Paul CorrisChris Ward1Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United KingdomGail Johnson2Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United KingdomVictoria Ryan3Institute of Health and Society, Newcastle University, Newcastle upon Tyne, United KingdomTherese Small2Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United KingdomJames Lordan2Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United KingdomAndrew Fisher1Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United KingdomGerard Meachery2Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United KingdomPaul Corris1Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
- Outcomes of lung transplantation for bronchiectasisBy Jodie Birch, Katy Hester, Gareth Parry, Kate Gould, John Dark, Stephen Clark, Gerard Meachery, James Lordan, Andrew Fisher, Paul Corris and Anthony De SoyzaJodie Birch1Transplantation and Immunobiology Group, Newcastle University, Newcastle upon Tyne, United KingdomKaty Hester2Sir William Leech Centre for Lung Research, Freeman Hospital, Newcastle upon Tyne, United KingdomGareth Parry4Transplantation and Immunobiology Group Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United KingdomKate Gould3Department of Medical Microbiology, Freeman Hospital, Newcastle upon Tyne, United KingdomJohn Dark4Transplantation and Immunobiology Group Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United KingdomStephen Clark4Transplantation and Immunobiology Group Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United KingdomGerard Meachery4Transplantation and Immunobiology Group Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United KingdomJames Lordan4Transplantation and Immunobiology Group Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United KingdomAndrew Fisher1Transplantation and Immunobiology Group, Newcastle University, Newcastle upon Tyne, United Kingdom4Transplantation and Immunobiology Group Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United KingdomPaul Corris1Transplantation and Immunobiology Group, Newcastle University, Newcastle upon Tyne, United Kingdom4Transplantation and Immunobiology Group Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United KingdomAnthony De Soyza1Transplantation and Immunobiology Group, Newcastle University, Newcastle upon Tyne, United Kingdom
- Epithelial cell regulation of immunity in cystic fibrosisBy Jane Falconer, Malcolm Brodlie, Sonya Carnell, Anthony de-Soyza, James Lordan, Paul Corris, Catharien Hilkens and Chris WardJane Falconer1Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, Tyne and Wear, United KingdomMalcolm Brodlie1Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, Tyne and Wear, United KingdomSonya Carnell1Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, Tyne and Wear, United KingdomAnthony de-Soyza1Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, Tyne and Wear, United KingdomJames Lordan2Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United KingdomPaul Corris1Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, Tyne and Wear, United KingdomCatharien Hilkens1Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, Tyne and Wear, United KingdomChris Ward1Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, Tyne and Wear, United Kingdom
- 'Idiopathic' pulmonary arterial hypertension with preserved lung function but co-existing parenchymal abnormalities: Response to treatment and survivalBy Yi Ling, Martin Johnson, David Kiely, Robin Condliffe, Charlie Elliot, J. Simon R Gibbs, Luke Howard, Joanna Pepke-Zaba, Karen Sheares, Paul Corris, Andrew Fisher, James Lordan, Sean Gaine, J. Gerry Coghlan, S. John Wort, Michael Gatzoulis and Andrew PeacockYi Ling1Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, United KingdomMartin Johnson1Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, United KingdomDavid Kiely2Sheffield Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, United KingdomRobin Condliffe2Sheffield Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, United KingdomCharlie Elliot2Sheffield Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, United KingdomJ. Simon R Gibbs3National Heart and Lung Institute, Imperial College London and Hammersmith Hospital, London, United KingdomLuke Howard3National Heart and Lung Institute, Imperial College London and Hammersmith Hospital, London, United KingdomJoanna Pepke-Zaba4Pulmonary Vascular Disease Unit, Papworth Hospital, Cambridge, United KingdomKaren Sheares4Pulmonary Vascular Disease Unit, Papworth Hospital, Cambridge, United KingdomPaul Corris5Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle, United KingdomAndrew Fisher5Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle, United KingdomJames Lordan5Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle, United KingdomSean Gaine6National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, IrelandJ. Gerry Coghlan7Pulmonary Hypertension Unit, Royal Free Hospital, London, United KingdomS. John Wort8Royal Brompton Pulmonary Hypertension and Adult Congenital Heart Centre, Brompton Hospital, London, United KingdomMichael Gatzoulis8Royal Brompton Pulmonary Hypertension and Adult Congenital Heart Centre, Brompton Hospital, London, United KingdomAndrew Peacock1Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, United Kingdom
- Antineutrophil cytoplasmic antibody (ANCA) associated lung-renal vasculitides: A single centre perspectiveBy Sarah McCloskey, Emma Browne, Matthew Lane, Laura Baines, Alison Brown and James LordanSarah McCloskey1Institute of Cellular Medicine, University of Newcastle upon Tyne, United KingdomEmma Browne1Institute of Cellular Medicine, University of Newcastle upon Tyne, United KingdomMatthew Lane1Institute of Cellular Medicine, University of Newcastle upon Tyne, United KingdomLaura Baines1Institute of Cellular Medicine, University of Newcastle upon Tyne, United KingdomAlison Brown1Institute of Cellular Medicine, University of Newcastle upon Tyne, United KingdomJames Lordan1Institute of Cellular Medicine, University of Newcastle upon Tyne, United Kingdom
- Pulmonary alveolar proteinosis due to monocytopenia: Lung transplant or haematopoeitic stem cell transplant?By Matthew Lane, Matt Collins, Venetia Bigley, Chris Morgan and James LordanMatthew Lane1Respiratory Department, Institute of Cellular Medicine, University of Newcastle upon Tyne/Freeman Hospital, Newcastle, United KingdomMatt Collins1Respiratory Department, Institute of Cellular Medicine, University of Newcastle upon Tyne/Freeman Hospital, Newcastle, United KingdomVenetia Bigley1Respiratory Department, Institute of Cellular Medicine, University of Newcastle upon Tyne/Freeman Hospital, Newcastle, United KingdomChris Morgan1Respiratory Department, Institute of Cellular Medicine, University of Newcastle upon Tyne/Freeman Hospital, Newcastle, United KingdomJames Lordan1Respiratory Department, Institute of Cellular Medicine, University of Newcastle upon Tyne/Freeman Hospital, Newcastle, United Kingdom
- Outcomes in embolisations of pulmonary arterio-venous malformationsBy Logan Thirugnanasothy, Sasiharan Sithamparanathan, Leslie Mitchell, Andrew Fisher, James Lordan and Paul CorrisLogan Thirugnanasothy1Cardiothoracics, Newcastle-upon-Tyne Hospitals, Newcastle, United KingdomSasiharan Sithamparanathan1Cardiothoracics, Newcastle-upon-Tyne Hospitals, Newcastle, United KingdomLeslie Mitchell1Cardiothoracics, Newcastle-upon-Tyne Hospitals, Newcastle, United KingdomAndrew Fisher2Institute of Cellular Medicine, University of Newcastle-upon-Tyne, Newcastle, United KingdomJames Lordan1Cardiothoracics, Newcastle-upon-Tyne Hospitals, Newcastle, United KingdomPaul Corris2Institute of Cellular Medicine, University of Newcastle-upon-Tyne, Newcastle, United Kingdom
- Portopulmonary hypertension in United Kingdom: A contemporary, national, observational studyBy Sasiharan Sithamparanathan, Logan Thirugnanasothy, Arun Nair, Gerry Coghlan, Charles Elliot, Andrew Fisher, Sean Gaine, Simon Gibbs, Michael Gatzoulis, Clive Handler, Luke Howard, Michael Johnson, David Kiely, James Lordan, Andrew Peacock, Joanna Pepke-Zaba, Ian Sabroe, Karen Sheares, Stephen Wort and Paul CorrisSasiharan Sithamparanathan1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomLogan Thirugnanasothy1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomArun Nair1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomGerry Coghlan1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomCharles Elliot1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomAndrew Fisher1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomSean Gaine1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomSimon Gibbs1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomMichael Gatzoulis1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomClive Handler1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomLuke Howard1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomMichael Johnson1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomDavid Kiely1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomJames Lordan1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomAndrew Peacock1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomJoanna Pepke-Zaba1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomIan Sabroe1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomKaren Sheares1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomStephen Wort1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United KingdomPaul Corris1Northern Pulmonary Vascular Unit, Freeman Hospital, Newcastle-upon-Tyne, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.